{
  "zip": "OX29 8LN",
  "sector": "",
  "fullTimeEmployees": 16,
  "longBusinessSummary": "e-Therapeutics plc engages in the discovery of drugs through its proprietary network-driven drug discovery platform in the United Kingdom. It is developing two NDD-derived immuno-oncology programs, including tryptophan catabolism and immune checkpoint modulation. The company, through its subsidiary, Searchbolt Limited, develops search engine technology. The company has collaborations with C4X Holdings PLC, Intellegens, Biorelate, Novo Nordisk, and Galapagos NV. e-Therapeutics plc was founded in 2001 and is based in Long Hanborough, the United Kingdom.",
  "city": "Long Hanborough",
  "phone": "44 1993 880 000",
  "country": "United Kingdom",
  "companyOfficers": [],
  "website": "http://www.etherapeutics.co.uk",
  "maxAge": 1,
  "address1": "17 Blenheim Office Park",
  "fax": "44 1993 880 207",
  "industry": "",
  "address2": "Oxfordshire",
  "previousClose": 0.23,
  "regularMarketOpen": 0.23,
  "twoHundredDayAverage": null,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.23,
  "navPrice": null,
  "averageDailyVolume10Day": null,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.23,
  "fiftyDayAverage": null,
  "trailingAnnualDividendRate": null,
  "open": 0.23,
  "averageVolume10days": null,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.23953,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.23,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 50000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": null,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": null,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.23,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 50000,
  "fiftyTwoWeekHigh": 0.23,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.23,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.23,
  "exchange": "PNK",
  "shortName": "E-THERAPEUTICS PLC",
  "longName": "e-therapeutics plc",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ETPPF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_23184200",
  "uuid": "724a10cf-2027-30cb-8c89-d19a6595a7ae",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": null,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1580428800,
  "heldPercentInstitutions": 0.097559996,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.59459996,
  "nextFiscalYearEnd": 1643587200,
  "mostRecentQuarter": 1596153600,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 157552750,
  "enterpriseValue": 96383040,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.23,
  "logo_url": "https://logo.clearbit.com/etherapeutics.co.uk"
}